We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Aflibercept for exudative AMD with persistent fluid on ranibizumab and/or bevacizumab.
- Authors
Kashani, Shahram
- Abstract
The article discusses research on exudative age-related macular degeneration (AMD). It references the study "Aflibercept for Exudative AMD With Persistent Fluid on Ranibizumab and/or Bevacizumab," by H. Cho and colleagues in a 2013 issue of " British Journal of Ophthalmology." The results of the study showed that 89% of patients who received a mean of 4.4 aflibercept injections showed anatomical improvement.
- Subjects
RETINAL degeneration; EYE diseases; RANIBIZUMAB; BEVACIZUMAB; OPHTHALMOLOGY
- Publication
Current Medical Literature: Ophthalmology, 2014, Vol 24, Issue 1, p24
- ISSN
0963-0112
- Publication type
Article